Admitted local publications that cite Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy.
No admitted local citation edges point to this work yet.
Cited by — Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy | ResearchHub - ResearchHub
